PR Newswire - Antengene Announces XPOVIO®'s New Indication Inclu...
SHANGHAI and HONG KONG, Nov. 28, 2024 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative, commercial-stage global biopharmaceutical company dedicat...
Read More

ภาษาไทย
English